The ChallengeA small molecule CDMO faced over a 70% turnover rate, struggled to meet product...
The ChallengeA small molecule CDMO faced over a 70% turnover rate, struggled to meet product...
A cardiovascular medical device company (a publicly traded company generating around $300 mi...
Learn how Barrington James successfully assembled a dedicated commercial team for a mid-size...
A mid-sized medical device company, specializing in cardiovascular and hematology faced a re...
We delivered market insights and a VP Finance shortlist, supporting a Swiss oncology biotech...
Explore how Barrington James effectively filled urgent Pharmacovigilance leadership roles fo...
We placed 135 hires in 4 years, enabling In Vivo department growth and meeting preclinical d...
We supported 57 hires over five years, driving CRO expansion, market share growth, and reput...